Clinical Trial - October 20, 2007

The Clinical Trial is a blind study which will track the results of the chemo drugs. Patients will be divided into two groups. One group will be administered the traditional dosage of both chemo medications, Cytarabine and Daunorubicin. The second group will receive double the dosage of Daunorubicin. The groupings are strictly random, with no input by patients or doctors. The primary benefit of the Clinical Study is that follow-up tracking and progress will be strictly enforced, well documented, and done under the umbrella of the Moffitt Hospital and research facilities; and any issues or problems will be quickly addressed. I was placed into the group receiving the double dosage of Daunorubicin. We hope more is better.